Table 5.
Demographic, Clinical and Laboratory Findings According to Fecal Calprotectin Positivity Rate in Obese Adolescent
| Fecal Calprotectin (µg/gr feces) | |||
|---|---|---|---|
| Variables | ≤ 50 (n = 10) |
> 50 (n = 21) |
P-values |
| Age (years, Median, Range) | 14(10–18) | 13 (10–17) | 0.474a |
| Gender (N, %) | 0.999b | ||
| Male | 5 (16.1%) | 12 (38.7%) | |
| Female | 5 (16.1%) | 9 (29.1%) | |
| Height(cm, Median, IQR) | 162 (152.7–169) | 165 (154.7-167.5) | 0.846a |
| Weight(kg, Median, IQR) | 88.3 (72.2-108.7) | 85.8 (74.1-104.4) | 0.859a |
| BMI (kg/m2, Median, IQR) | 32.94 (27.6–35.7) | 31.9 (28.75–34.87) | 0.164a |
| BMI SD (Median, IQR) | 2.68 (2.05–2.89) | 2.42 (2.26–2.87) | 0.234a |
| Waist Circumference(cm, Median, IQR) | 111.3 (94.2–121) | 102 (96.5–115) | 0.164a |
| ALT (IU/L, Median, IQR) | 24 (14–59) | 25 (17.5–38) | 0.983a |
| HbA1c (%, Median, IQR) | 5.55 (5.35–5.625) | 5.5 (5.25–5.7) | 0.423a |
| Glucose (mmol/L, Median, IQR) | 4.3 (4.16–4.52) | 4.7 (4.36–5.33) | 0.667a |
| HOMA-IR (Median, IQR) | 2 (1.7–2.42) | 2.68 (1.86–5.27) | 0.188a |
| Cholesterol (mmol/L, Median, IQR) | 8.83 (7.61–9.38) | 8.245 (7.35–9.25) | 0.724a |
| Triglycerides (mmol/L, Median, IQR) | 5.59 (3.19–8.69) | 6.38 (4.81–7.62) | 0.272a |
| Abdominal USG (N, %) | 0.119b | ||
| No Hepatosteatosis | 5 (16.1%) | 6 (19.4%) | |
| Grade-I Hepatosteatosis | 1 (3.2%) | 10 (32.3%) | |
| Grade-II Hepatosteatosis | 4 (12.9%) | 5 (16.1%) | |
a: Mann Whitney U Test; b: Fisher’s Exact Test
ALT: Alanine Aminotransferase, CRP: C-Reactive Protein, dL: Desiliter, gr: gram, IU: International Unit, IQR: Interquartile Range, kg: kilogram, L: Liter, m: meter, mg: miligram, µg: microgram, mmol: Milimol, NAFLD: Non-Alcoholic Fatty Liver Disease
All percentages were calculated based on the obese patient population (N = 31)